FEDERATED HERMES, INC. - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 136 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 12.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,825
-25.0%
1,4150.0%0.00%
Q2 2023$2,434
+13.9%
1,4150.0%0.00%
Q1 2023$2,137
-62.3%
1,415
-60.1%
0.00%
Q4 2022$5,667
-5.6%
3,542
-16.8%
0.00%
Q3 2022$6,000
-14.3%
4,257
+11.1%
0.00%
Q2 2022$7,000
+600.0%
3,833
+4632.1%
0.00%
Q1 2022$1,000
-100.0%
81
-100.0%
0.00%
-100.0%
Q4 2021$4,163,000
-15.0%
961,474
-0.0%
0.01%
-11.1%
Q3 2021$4,895,000
-17.0%
961,597
+3.2%
0.01%
-18.2%
Q2 2021$5,900,000
+28.6%
932,007
+57.1%
0.01%
+22.2%
Q1 2021$4,587,000
+93.1%
593,421
+63.6%
0.01%
+80.0%
Q4 2020$2,375,000
+1830.9%
362,658
+1863.3%
0.01%
Q3 2020$123,000
+115.8%
18,472
+170.9%
0.00%
Q2 2020$57,000
+11.8%
6,819
-2.2%
0.00%
Q3 2019$51,000
-98.6%
6,970
-94.5%
0.00%
-100.0%
Q1 2018$3,583,000
+144.7%
125,932
+81.6%
0.01%
+150.0%
Q4 2017$1,464,00069,3500.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
BVF INC/IL 5,803,700$25,130,0000.91%
Altium Capital Management LP 663,800$2,874,0000.79%
Rubric Capital Management LP 2,406,449$10,420,0000.49%
RTW INVESTMENTS, LP 6,029,700$26,109,0000.38%
Orbimed Advisors 3,214,509$13,919,0000.18%
TANG CAPITAL MANAGEMENT LLC 152,345$660,0000.13%
PLATINUM INVESTMENT MANAGEMENT LTD 980,085$4,244,0000.12%
Point72 Asset Management, L.P. 6,303,025$27,292,0000.11%
Sender Co & Partners, Inc. 40,720$176,0000.09%
Manteio Capital LLC 15,067$65,0000.08%
View complete list of CYTOMX THERAPEUTICS INC shareholders